MGTX MeiraGTx Holdings plc
$12.61▼ -2.14%
Healthcare
Other
Volume 247.2K
Avg Volume (10D) 639.4K
Key Metrics & Fundamentals
Market Cap
$1.21B
P/E Ratio
14.5
Div Yield
–%
52W Range
6.62 - 15.35
% vs 50 MA
-2.31%
% vs 200 MA
30.69%
RSI-14
41.7
MACD Histogram
-0.2300
Beta (1Y vs SPY)
1.65
Free Cash Flow
-$62.85M
Gross Rev
$321.43M
Gross Profit
$314.27M
EBITDA
$176.05M
COGS
$7.16M
Operating Exp
$69.85M
Operating Income
$244.43M
EBIT
$244.43M
Pretax Income
$163.03M
Net Income
$160.72M
EPS (Diluted)
1.71
Price & Volume History
Loading chart…
Recent News
Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
PR Newswire · Aug 26, 2026 2:49 PM
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal?
Simply Wall St. · Aug 14, 2026 11:12 PM
MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says
MT Newswires · Aug 14, 2026 4:02 PM
RBC Adjusts PT on MeiraGTx to $27 From $26, Maintains Outperform Speculative Risk Rating
MT Newswires · Aug 14, 2026 11:39 AM
Sector Update: Healthcare Stocks Softer in Afternoon Trading
MT Newswires · Aug 13, 2026 5:50 PM
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
Zacks · Aug 13, 2026 1:25 PM
Sector Update: Healthcare Stocks Advance Pre-Bell Thursday
MT Newswires · Aug 13, 2026 1:13 PM
Sector Update: Healthcare
MT Newswires · Aug 13, 2026 12:58 PM
MeiraGTx Swings to Q2 Profit, Revenue Rises
MT Newswires · Aug 13, 2026 12:17 PM
MeiraGTx Reports Second Quarter 2026 Financial and Operational Results
GlobeNewswire · Aug 13, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See MGTX's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.